Independent investigators and for-profit companies. Guidelines for biomedical scientists considering funding by industry
Chren, M.M.
Archives of Dermatology 130(4): 432-437
1994
ISSN/ISBN: 0003-987X PMID: 8166481 Document Number: 431646
Document emailed within 1 workday
Related Documents
Candy, D.C. 1999: Should industry sponsor research? Funding of research by infant formula companies Bmj 318(7178): 260Berns, D.S.; Silbermann, M. 1994: Overview of research in the medical sciences in Israel: institutions, investigators and funding Israel Journal of Medical Sciences 30(11): 801-805
Botkin, J.R.; McMahon, W.M.; Smith, K.R.; Nash, J.E. 1998: Privacy and confidentiality in the publication of pedigrees: a survey of investigators and biomedical journals JAMA 279(22): 1808-1812
Limbacher, P.B. 1998: Off the beaten path. more for-profit hospital companies traveling to rural markets Modern Healthcare 28(14): 67-72
2014: Most profitable U.S. drug and biologic companies. Ranked by 2013 profit margin Modern healthcare Suppl: 30
Whidden, P. 1997: The tobacco industry and scientific publications. Findings of scientists who were and were not funded by tobacco industry were strikingly different Bmj 314(7090): 1350-1351
D'Auria, J. 1998: Brown and Tufts scientists among those to receive NIH funding for AIDS research Journal of Investigative Medicine: the Official Publication of the American Federation for Clinical Research 46(9): 421
Watts, G. 2010: Scientists respond to UK business secretary's warning of cuts in research funding Bmj 341: C4983
Frame, J.D.; Narin, F. 1976: NIH funding and biomedical publication output Federation Proceedings 35(14): 2529-2532
Narine, N.; Rana, D.N.; Perera, D.M.; Irshad, A. 2012: Value of biomedical scientists providing on-site specimen adequacy assessment for fine-needle aspirations British Journal of Biomedical Science 69(3): 108-111
Busby, J. 1991: Ties that bind? the web of CME and medical industry profit Texas Medicine 87(8): 38-46
Galloro, V. 2004: Blizzard deals. in a sure sign of a robust industry, companies recently have gotten in the spirit to merge and acquire Modern Healthcare 34(50): 6-7; 1
Wolfe, S.M. 2014: Does $760 m a year of industry funding affect the FDA's drug approval process? Bmj 349: G5012
Bergmann, J.F.; Lagier, G.; Calvo, F.; Chazelle, F.; Caulin, C. 1988: Independent controls of quality in therapeutic trials. Apropos of an experience of 11 external audits of clinical investigators performed in 2 European multicenter trials Therapie 43(5): 379-384
Coussins, J. 1999: Should industry sponsor research? Portman Group has always openly acknowledged its source of funding Bmj 318(7178): 261
Blomquist, C. 1975: Ethical guidelines for biomedical research Annals of Clinical Research 7(5): 291-294
Becker, C. 2006: Charitable intentions. CHA, VHA unveil community-benefit guidelines developed to help not-for-profit hospitals justify their tax exemptions Modern Healthcare 36(23): 6-7 14 1
Rácz, Zán. 2004: Guidelines for writing biomedical articles containing statistical figures and analysis Orvosi Hetilap 145(3): 131-137
Eliasson, G.; Håkansson, J. 2001: Keep medical education independent! it should not be a scene of drug industry marketing Lakartidningen 98(39): 4168-4169
Finer, D. 1988: African scientists and scientists from the West work together on AIDS research Lakartidningen 85(50): 4451-4453